Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-04 Sale | 2024-11-06 6:52 pm | Origin Materials Inc. | ORGN | Plavan Matthew T Chief Financial Officer | 120,000 | $1.3155 | $157,860 | 1,223,088 (Direct) | View |
| 2020-08-03 Purchase | 2021-01-25 6:51 pm | Arcadia Biosciences Inc. | RKDA | Plavan Matthew T Chief Executive Officer | 585 | $3.16 | $1,849 | 449,735 (Direct) | View |
| 2020-02-03 Purchase | 2020-02-04 4:11 pm | Arcadia Biosciences Inc. | RKDA | Plavan Matthew T Chief Executive Officer | 700 | $1.72 | $1,204 | 199,150 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-26 Option Award | 2023-12-28 4:21 pm | N/A N/A | Origin Materials Inc. | ORGN | Plavan Matthew T Chief Financial Officer | 241,105 | $0 | 1,343,088 (Direct) | View |
| 2023-10-30 Option Award | 2023-11-01 4:47 pm | N/A N/A | Origin Materials Inc. | ORGN | Plavan Matthew T Chief Financial Officer | 1,101,983 | $0 | 1,101,983 (Direct) | View |
Ownership | 2023-11-01 4:45 pm | N/A N/A | Origin Materials Inc. | ORGN | Plavan Matthew T Chief Financial Officer | 0 | $0 | 0 (Direct) | View |
| 2021-01-21 Option Award | 2021-01-25 6:51 pm | N/A 2031-01-21 | Arcadia Biosciences Inc. | RKDA | Plavan Matthew T Chief Executive Officer | 250,000 | $0 | 449,735 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-04 4:11 pm | N/A 2030-02-03 | Arcadia Biosciences Inc. | RKDA | Plavan Matthew T Chief Executive Officer | 76,000 | $0 | 199,150 (Direct) | View |